Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pharvaris N.V.PHVS · Entity 4374 | Chief Technical Ops Officer | September 15, 2026 | September 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pharvaris N.V.
Report date September 15, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 39,068 |
Ending reported balance
After 2026-09-15 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2026-09-15 · Exercise / conversion · Acquired 45,000 · Balance 85,468 Row 2 · 2026-09-15 · Sale · Disposed 45,000 · Balance 40,468 F1: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $38.00 to $38.35. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Row 3 · 2026-09-15 · Sale · Disposed 1,400 · Balance 39,068 F2: The reported price represents a weighted average sale price for shares sold in multiple transactions at prices ranging from $39.2150 to $39.27 per share. The shares sold were acquired upon vesting of restricted stock units on various dates. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $16.40 · Expires 2033-11-15 | Direct | 44,500 |
Reported balance
After 2026-09-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-15 · Exercise / conversion · Disposed 45,000 · Balance 44,500 F3: 25% of the option vested on November 15, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $38.00 to $38.35. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F2: The reported price represents a weighted average sale price for shares sold in multiple transactions at prices ranging from $39.2150 to $39.27 per share. The shares sold were acquired upon vesting of restricted stock units on various dates. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
F3: 25% of the option vested on November 15, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 17, 2026 17:22 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionStock Option (Right to Buy) · Derivative | 45,000 | $0.00 Strike: $16.40 | $0.00 |
DisclosureSEC source: 0001193125-26-394103 · ownership.xml · derivative · entry 4 Abele Stefan Andreas · CIK 0002002390 · Chief Technical Ops Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,500 Underlying: Common Stock · 45,000 shares Expires 2033-11-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the option vested on November 15, 2024 with the remaining shares vesting in 1/48 monthly installments thereafter. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 17:22 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 1,400 | $39.24 | $54,937.54 |
DisclosureSEC source: 0001193125-26-394103 · ownership.xml · nonDerivative · entry 3 Abele Stefan Andreas · CIK 0002002390 · Chief Technical Ops Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,068 F2 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions at prices ranging from $39.2150 to $39.27 per share. The shares sold were acquired upon vesting of restricted stock units on various dates. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 17:22 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 45,000 | $38.14 | $1,716,187.50 |
DisclosureSEC source: 0001193125-26-394103 · ownership.xml · nonDerivative · entry 2 Abele Stefan Andreas · CIK 0002002390 · Chief Technical Ops Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,468 F1 · price: The reported price represents a weighted average sale price for shares sold in multiple transactions on the reported date. The shares were sold in connection with the exercise of stock options in a cashless exercise transaction. The sales prices for the transactions ranged from $38.00 to $38.35. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 15, 2026 Filed Sep 17, 2026 17:22 UTC | Pharvaris N.V. PHVS · Entity 4374 | Exercise / conversionCommon Stock | 45,000 | $16.40 | $738,000.00 |
DisclosureSEC source: 0001193125-26-394103 · ownership.xml · nonDerivative · entry 1 Abele Stefan Andreas · CIK 0002002390 · Chief Technical Ops Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 15, 2026 Filed May 19, 2026 22:44 UTC | Pharvaris N.V. PHVS · Entity 4374 | SaleCommon Stock | 8,748 | $29.82 | $260,864.49 |
DisclosureSEC source: 0001193125-26-231281 · ownership.xml · nonDerivative · entry 1 Abele Stefan Andreas · CIK 0002002390 · Chief Technical Ops Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,194 F1 · price: The shares reported herein include shares of common stock acquired upon vesting of restricted stock units on various dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.